ProPhase Labs (PRPH) reminds shareholders of record as of October 20, 2025, of the Company’s upcoming Special Meeting of Stockholders, which will be held on November 24, 2025. The company said, “By voting FOR all proposals, shareholders will enable ProPhase Labs to advance its long-term strategic vision, including potential strategic initiatives that the Company anticipates updating shareholders on in the near future as well as actions designed to maintain compliance with Nasdaq listing requirements. These proposals, taken together, position the Company to continue executing on its innovation-driven business strategy while giving the Board the tools necessary to pursue emerging opportunities that may drive future growth and stockholder value.”
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRPH:
- ProPhase Labs Delays Q3 Filing Amid Reorganization
- ProPhase Labs announces publication of BE-Smart Esophageal Cancer study
- ProPhase Labs engages RedChip to lead investor relations efforts
- ProPhase Labs announces study validating BE-Smart cancer test
- ProPhase Labs files to sell 226.31M shares of common stock for holders
